FDA Oversight & Regulation - FDA aims to remove industry members from advisory committees where possible to preserve the scientific process [1] - FDA needs to monitor drugs and devices immediately after approval to detect safety signals early [2] - The industry should not wait 19 years after a drug's approval to learn about potentially fatal downstream effects, such as the alleged million deaths linked to Oxycontton [2] - FDA is eliminating the ability of a small group of bureaucrats to block safety epidemiology studies [3] - The safety team should work freely without barriers to evaluate drug safety [3] Potential Conflicts of Interest - There is a potential conflict of interest if the team that approved a drug is also responsible for evaluating its safety [4]
Dr. Makary: “The FDA did fail” on OxyContin #shorts #oxycontin #fda #wallstreetweek
Bloomberg Television·2025-07-11 23:18